The purpose of this study is to determine whether physicians can be educated to better handle inappropriate requests from patients for direct-to-consumer advertised prescription medications.
Since changes in FDA regulation direct-to-consumer advertising (DTCA), pharmaceutical companies have expended increasing resources to market their products to the public. This has led to increased awareness of diseases and potential treatments, but it has also created more public demand for medications that may not be appropriate for a patient's clinical presentation. This study aims to provide physicians with the knowledge and skills required to help them address inappropriate DTCA medication requests from patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
SINGLE
Enrollment
133
Interactive case-based modules that includes video vignettes of clinical interactions between hypothetical patients interacting with physicians
Stanford University School of Medicine
Stanford, California, United States
Creighton University School of Medicine
Omaha, Nebraska, United States
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania, United States
University of Texas at Houston Medical School
Houston, Texas, United States
Decision to prescribe celecoxib
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.